As of 2024-12-15, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.08. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 0.53 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -6.75 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.3x - 11.9x | 10.4x |
| Forward P/E multiples | 2.2x - 5.7x | 2.7x |
| Fair Price | (0.46) - (0.31) | (0.36) |
| Upside | -3163.7% - -2191.8% | -2496.9% |
| Date | EV/EBITDA |
| 2024-12-10 | 0.01 |
| 2024-12-06 | 0.01 |
| 2024-12-02 | -0.08 |
| 2024-11-27 | -0.17 |
| 2024-11-26 | -0.17 |
| 2024-11-25 | -0.17 |
| 2024-11-22 | -0.08 |
| 2024-11-21 | 0.01 |
| 2024-11-19 | 0.01 |
| 2024-11-11 | 0.01 |
| 2024-10-30 | 0.01 |
| 2024-10-24 | 0.01 |
| 2024-10-17 | 0.01 |
| 2024-10-16 | 0.01 |
| 2024-10-07 | -0.08 |